2000
DOI: 10.1073/pnas.97.2.783
|View full text |Cite
|
Sign up to set email alerts
|

Drug target validation: Lethal infection blocked by inducible peptide

Abstract: Genome projects are generating large numbers of potential new targets for drug discovery. One challenge is target validation, proving the usefulness of a specific target in an animal model. In this paper, we demonstrate a new approach to validation and assay development. We selected in vitro specific peptide binders to a potential pathogen target. By inducing the expression of a selected peptide in pathogen cells causing a lethal infection in mice, the animals were rescued. Thus, by combining in vitro selectio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
24
0

Year Published

2000
2000
2022
2022

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 50 publications
(24 citation statements)
references
References 14 publications
0
24
0
Order By: Relevance
“…18) have successfully been used in yeast cells, E. coli, Drosophila, and cultured human cells. They are a useful tool for basic research, but they also represent a new approach in drug target validation and drug discovery (18,19,(31)(32)(33)(34). The application of dominant negative peptide aptamers to inhibit protein functions in vivo in a living multicellular organism has been reported so far only for Drosophila (19,35).…”
Section: Discussionmentioning
confidence: 99%
“…18) have successfully been used in yeast cells, E. coli, Drosophila, and cultured human cells. They are a useful tool for basic research, but they also represent a new approach in drug target validation and drug discovery (18,19,(31)(32)(33)(34). The application of dominant negative peptide aptamers to inhibit protein functions in vivo in a living multicellular organism has been reported so far only for Drosophila (19,35).…”
Section: Discussionmentioning
confidence: 99%
“…Peptides were synthesized to include the 12-to 15-amino-acid sequence displayed by the phage followed by a short linker and a biotin at the C terminus to allow labeling for analysis of peptide binding. Isolation and use of ProRS-specific phage has been described previously (24,46); peptide Pro-3 in those publications is referred to as peptide 72 in this work.…”
mentioning
confidence: 99%
“…In an extension of our previous work in isolating a peptide inhibitor of prolyl-tRNA synthetase (ProRS) (24), Tao et al showed that intracellular expression of this peptide fused to GST could slow bacterial growth and rescue mice from an otherwise lethal dose of virulent Escherichia coli. (46). Specific inhibition of ProRS in the cell was demonstrated by a decrease in the intracellular pool of charged tRNA Pro .…”
mentioning
confidence: 99%
“…Information obtained from peptide library approaches also provides useful information and tools for drug discovery. For example, binding information derived from phage display methods has been used to validate particular proteins as potential drug targets in vivo (Stauffer et al, 1997;Tao et al, 2000). In addition, phage display ligands have been used to guide the design of peptidomimetics and for development of high-throughput small molecule inhibitor screens (Kay et al, 1998;Gron et al, 2000).…”
Section: Discussionmentioning
confidence: 99%